融捷健康
(300247)
| 流通市值：35.26亿 | | | 总市值：35.30亿 |
| 流通股本：8.03亿 | | | 总股本：8.04亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 432,764,125.61 | 251,599,497.82 | 688,791,514.9 | 475,799,143.25 |
| 营业收入 | 432,764,125.61 | 251,599,497.82 | 688,791,514.9 | 475,799,143.25 |
| 二、营业总成本 | 358,398,007.27 | 198,022,819.87 | 605,599,476.73 | 421,217,244.54 |
| 营业成本 | 277,773,111.91 | 166,005,418.26 | 469,656,515.82 | 329,079,603.45 |
| 税金及附加 | 3,578,180.45 | 1,410,855.54 | 4,839,108.7 | 4,311,745.34 |
| 销售费用 | 36,747,030.15 | 17,622,024.09 | 70,291,044.61 | 39,532,241.97 |
| 管理费用 | 40,054,899.96 | 13,298,108.82 | 64,828,341.46 | 48,035,007.49 |
| 研发费用 | 5,953,591.68 | 2,904,875.58 | 11,697,173.96 | 8,312,855.5 |
| 财务费用 | -5,708,806.88 | -3,218,462.42 | -15,712,707.82 | -8,054,209.21 |
| 其中:利息收入 | 6,041,255.9 | - | - | - |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 5,078,785.47 | 1,491,761.02 | 5,664,711.71 | 8,155,952.84 |
| 加:投资收益 | 421,795.82 | 14,963.53 | 2,885,361.58 | 2,526,413.32 |
| 资产处置收益 | -4,931.83 | -6,842.65 | 5,956.74 | 35,583.94 |
| 资产减值损失(新) | 151,600.05 | -493.87 | -3,120,996.34 | 47,611.25 |
| 信用减值损失(新) | 1,239,226.32 | 282,162.01 | -1,551,092.36 | -593,287.54 |
| 其他收益 | 848,066.09 | 474,257.12 | 1,056,161.42 | 892,334.39 |
| 四、营业利润 | 82,100,660.26 | 55,832,485.11 | 88,132,140.92 | 65,646,506.91 |
| 加:营业外收入 | 1,028,963.58 | 977,801.32 | 1,093,747 | 358,427.17 |
| 减:营业外支出 | 35,732.91 | 22,544.13 | 1,072,146.08 | 141,531.43 |
| 五、利润总额 | 83,093,890.93 | 56,787,742.3 | 88,153,741.84 | 65,863,402.65 |
| 减:所得税费用 | 18,932,203.03 | 13,746,015.31 | 22,096,553.63 | 15,728,098.5 |
| 六、净利润 | 64,161,687.9 | 43,041,726.99 | 66,057,188.21 | 50,135,304.15 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 64,161,687.9 | 43,041,726.99 | 66,057,188.21 | 50,135,304.15 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 47,523,740.22 | 30,984,169.91 | 46,854,048.65 | 36,436,656.27 |
| 少数股东损益 | 16,637,947.68 | 12,057,557.08 | 19,203,139.56 | 13,698,647.88 |
| 扣除非经常损益后的净利润 | 39,075,334.93 | 28,178,773.25 | 39,375,335.61 | 35,403,001.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.04 | 0.06 | 0.05 |
| (二)稀释每股收益 | 0.06 | 0.04 | 0.06 | 0.05 |
| 八、其他综合收益 | -1,373,652.2 | -521,624.88 | 3,059,652.92 | -3,571,132.45 |
| 归属于母公司股东的其他综合收益 | -892,873.93 | -339,056.17 | 1,988,774.4 | -2,321,236.09 |
| 九、综合收益总额 | 62,788,035.7 | 42,520,102.11 | 69,116,841.13 | 46,564,171.7 |
| 归属于母公司股东的综合收益总额 | 46,630,866.29 | 30,645,113.74 | 48,842,823.05 | 34,115,420.18 |
| 归属于少数股东的综合收益总额 | 16,157,169.41 | 11,874,988.37 | 20,274,018.08 | 12,448,751.52 |
| 公告日期 | 2025-08-27 | 2025-04-25 | 2025-04-23 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |